Elevance Health (ELV) is a publicly traded Healthcare sector company. As of October 2, 2026, ELV trades at $387.67 with a market cap of $82.77B and a P/E ratio of 15.28. ELV moved +1.25% today. Year to date, ELV is +9.08%; over the trailing twelve months it is +13.58%. Its 52-week range spans $273.71 to $458.75. Analyst consensus is buy with an average price target of $445.88. Rallies surfaces ELV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ELV insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $387.67 |
| Market Cap | $82.77B |
| P/E Ratio | 15.28 |
| EPS | $25.28 |
| Dividend Yield | 1.72% |
| 52-Week High | $458.75 |
| 52-Week Low | $273.71 |
| Volume | 630.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $199.13B |
| Net Income | $5.66B |
| Gross Margin | 89.36% |
18 analysts cover ELV: 0 strong buy, 11 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $445.88.